Merck announces positive results from phase 2 trial evaluating coformulation of vibostolimab, pembrolizumab in lung cancer patients Ruchika Sharma10 Dec 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced full results from the non-registrational Phase 2 KeyVibe-002...
Sanofi multiple myeloma drug Sarclisa phase 3 trial meets primary endpoint of progression-free survival Ruchika Sharma10 Dec 2023 11:30 AM ISTParis: Sanofi has announced that the Phase 3 IMROZ trial evaluating the investigational use of Sarclisa (isatuximab) in combination with...
Merck-Eisai endometrial cancer therapy combo fails first-line treatment trial Ruchika Sharma9 Dec 2023 1:30 PM ISTRahway: Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line...
Pfizer Elrexfio gets European Commission approval for Multiple Myeloma Ruchika Sharma9 Dec 2023 12:00 PM ISTThe conditional marketing authorization for ELREXFIO is valid in all 27 EU member states as well as Iceland, Liechtenstein, and Norway.
Use of GLP-1 drugs in type 2 diabetes tied to reduced risk of colorectal cancer: JAMA Medha Baranwal9 Dec 2023 11:30 AM ISTUSA: A nationwide cohort study revealed a greater reduction in the risk of colorectal cancer (CRC) with the use of glucagon-like peptide 1 (GLP-1)...
Merck to stop phase 3 trial of Keytruda plus Lynparza for lung cancer patients Ruchika Sharma8 Dec 2023 3:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it will stop the Phase 3 KEYLYNK-008 trial evaluating...
Bristol Myers Squibb Abecma approved for use in earlier lines of therapy for patients with relapsed or refractory Multiple Myeloma in Japan Ruchika Sharma7 Dec 2023 4:30 PM ISTTokyo: Bristol-Myers Squibb K.K. has announced that the company has received manufacturing and marketing approval of the supplemental New Drug...
USFDA accepts for priority review Bristol Myers Squibb application for Opdivo plus Cisplatin-Based Chemotherapy for urothelial carcinoma Ruchika Sharma7 Dec 2023 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License...
Long-chain fatty acid in beef and dairy improves immune response to cancer, study finds Dr. Kamal Kant Kohli7 Dec 2023 12:00 PM ISTUSA: A recent study published in Nature has shown that trans-vaccenic acid (TVA) improves the ability of CD8+ T cells to infiltrate tumours and kill...
Studies help explain why some prostate cancers become resistant to hormone therapy Roshni Dhar7 Dec 2023 9:15 AM ISTTwo new studies led by researchers from the UCLA Jonsson Comprehensive Cancer Center give insight into how cells use energy to influence the way...
Persistent Health Challenges Faced by LGB Survivors of Adolescent and Young Adult Cancers Roshni Dhar7 Dec 2023 9:00 AM ISTStudies have indicated that minority sexual orientation and gender identity populations have higher prevalence rates of many chronic conditions...
Consumption of ultra-processed foods tied to higher risk of mouth, throat and oesophagus cancers: Study Dr. Kamal Kant Kohli7 Dec 2023 7:45 AM ISTUK: A recent study published in the European Journal of Nutrition has revealed an association between ultra-processed foods (UPF) consumption and a...
